AAPL 204.61 +0.13 (+0.06%)MSFT 123.75 +0.14 (+0.11%)FB 181.79 +1.28 (+0.71%)ZNGA 5.52 +0.05 (+1.01%)NVDA 188.48 +0.19 (+0.10%)WBA 54.09 -0.26 (-0.48%)GOOG 1248.72 +4.8 (+0.39%)PIH 5.25 -0.05 (-0.94%)
AAPL 204.61 +0.13 (+0.06%)MSFT 123.75 +0.14 (+0.11%)FB 181.79 +1.28 (+0.71%)ZNGA 5.52 +0.05 (+1.01%)NVDA 188.48 +0.19 (+0.10%)WBA 54.09 -0.26 (-0.48%)GOOG 1248.72 +4.8 (+0.39%)PIH 5.25 -0.05 (-0.94%)

Balance Sheet ACAD Quote ACADIA Phar

All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Year 201420152016
CashAndCashEqui 164 69 135
ShortTermInvest 365 272 339
Cash 529 341 474
AccountReceivab 6 17 26
Inventories 4 5 4
DeferredIncomeT 0 0 0
OtherCurrentAss 1 1 2
TotalCurrentAss 548 373 526
PPE 6 7 8
AccumulatedDepr -3 -4 -4
NetPPE 3 3 3
EquityAndOtherI 0 0 0
Goodwill 0 0 0
IntangibleAsset 7 6 4
OtherLTAssets 3 3 7
TotalNonCurrent 13 11 14
TotalAssets 561 385 540
ShortTermDebt 0 0 0
AccountsPayable 4 9 3
TaxesPayable 0 0 0
AccruedLiabilit 22 25 39
DeferredRevenue 3 0 0
OtherCurrentLia 14 15 17
TotalCurrentLia 43 49 60
Debt 0 0 0
DeferredTaxesLi 0 0 0
DeferredRevenue 0 0 0
OtherLTLiabilit 0 0 2
TotalNonCurrent 0 0 2
TotalLiabilitie 43 49 61
CommonStock 0 0 0
AdditionalPaidI 1,452 1,559 1,948
RetainedEarning -934 -1,224 -1,469
AccumulatedOthe 0 0 0
TotalStockholde 518 335 479
TotalLiabilitie 561 385 540
ACADIA Pharmaceuticals Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes ACADIA Pharmaceuticals Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.